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Abstract
Introduction: Subarachnoidal hemorrhage (SAH) occurring after aneurismal rupture produces an inflammatory response in
the cerebral circulation. Tumor necrosis factor (TNF)-α is a major cytokine in this process. Adhesion molecules provide
information on inflammatory reactions taking place in the walls of blood vessels. Clinical evidence suggests a role of soluble
intercellular adhesion molecule (sICAM)-1 in early hemorrhagic events. This study aimed to evaluate the implementation
of early TNF-α and sICAM-1 serum measurement for the prognosis of patient outcome after intracranial aneurismal
rupture. 
Materials and Methods: The study consisted of 27 patients with a diagnosis of intracranial aneurysm. SAH was evaluated on
admission according to the Fisher scale, patients’ consciousness with the Glasgow Coma Scale, clinical grading with the Hunt
and Hess scale, and clinical outcome with the Glasgow Outcome Scale (GOS). Blood samples were drawn within 72 h after
arrival at the emergency room. Serum concentrations of TNF-α and sICAM-1 were assayed with the ELISA method.
Results: The initial serum TNF-α concentration in the aneurismal patients was low and did not correlate with radiological
and clinical scores. The serum sICAM-1 level positively correlated with the severity of bleeding assessed by the Fisher scale
and negatively with the patient’s scoring in the GOS.
Conclusions: This study demonstrated the absence of a systemic TNF-α-mediated inflammatory response at the onset of sub-
arachnoid hemorrhage. Early measurement of serum sICAM-1 levels offers a potential prognostic value in the assessment
of patients’ outcome after brain aneurismal rupture.
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INTRODUCTION
Intracranial aneurysms are often defined as weak-
ened, abnormally dilated walls of the major arteries
(Selman et al. 2000). The aneurysm is usually asympto-
matic for a long time until rupture (Raps et al. 1993).
A consequence of an aneurismal wall burst is blood
leakage into the cerebral structures, which may lead to
irreversible brain damage and death (Inagawa et al.
1995). The incidence of intracranial aneurismal in the
general population is estimated to be about 4–6%
(Rinkel et al. 1998). Inherited syndromes, traumatic or
infectious diseases, and behavioral influences have been
specified among the risk factors (De Braekeleer et al.
1996; Wardlaw and White 2000). Subjects of female
gender, aged over 50, hypertensive, hypercholes-
terolemic, or with a current smoking history are prone
to develop brain aneurysms (Wardlaw and White 2000).
Coffee consumption may increase the incidence of
aneurismal subarachnoidal hemorrhage (SAH) (Isaksen
et al. 2002). The potential influence of alcohol con-
sumption is under investigation (Wardlaw and White
2000).
SAH occurring after aneurismal rupture produces
an inflammatory response in the cerebral circulation
mediated by proinflammatory cytokines (Fassbender et
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al. 2001; Takizawa et al. 2001). Tumor necrosis factor
(TNF)-α is one of the key immune activators of leuko-
cytes counteracting the underlying pathological condi-
tion. Stimulated by cytokines, the inflammatory process
may promote the development of cerebral vasospasm
and ischemia, which negatively affect a patient’s out-
come after SAH (Dumont et al. 2003; Hirashima et al.
1997). 
Adhesion molecules provide information on inflam-
matory reactions which occur in the walls of blood ves-
sels (Witkowska 2005). Soluble intercellular adhesion
molecule (sICAM)-1 is a circulating form of ICAM-1,
a molecule that is crucial for leukocyte adhesion to
endothelial cells in the process of leukocyte migration
through the vessel’s wall. Clinical evidence suggests that
sICAM-1 may be engaged in the process of cerebral
vasospasm (Mocco et al. 2002), and late elevated levels
of serum sICAM-1 were predictors of poor outcome
after aneurismal SAH (Mack et al. 2002).
Inflammatory cytokines and adhesion molecules
may contribute to complications after intracranial hem-
orrhage, with dramatic consequences for the
patient’s survival (Dhar and Diringer 2008; Dumont et
al. 2003). Hence this study aimed to evaluate the rela-
tionships between early TNF-α and sICAM-1 serum lev-
els and prognosis after aneurismal rupture.
MATERIALS AND METHODS
The protocol of the study was approved by the local
bioethics committee. The participants were 27 patients
with a diagnosis of ruptured intracranial aneurysm
admitted to the Department of Neurosurgery for life-
saving surgery. Their detailed data are shown in Table 1.
Seventeen healthy subjects of both genders, aged
between 38–71 years (mean age: 55 years), took part in
the examinations as the control group. 
SAH was evaluated on admission using computed
tomography and graded according to the Fisher scale
(Fisher et al. 1980). The patients’ consciousness was
graded with the Glasgow Coma Scale (GCS) (Teasdale
and Jennett 1974). Clinical grading was performed with
the Hunt and Hess scale (Hunt and Hess 1968). Grading
with the Fisher scale, GCS, and Hunt and Hess scale
was available for 24 patients (the other 3 patients died
before clinical assessment). Clinical outcome of the
patients was assessed according to the Glasgow
Outcome Scale (GOS) (Jennett and Bond 1975).
Venous blood samples were drawn within 72 h after
arrival at the emergency room. Blood was collected into
Vacutainer System test tubes containing a clotting acti-
vator (Becton Dickinson, France). The samples were
allowed to clot for 30 min. After 10-minute centrifuga-
tion at an relative centrifugal force of 1000 g, the serum
was pipetted into Eppendorf test tubes and kept frozen at
–20 C. The serum samples were thawed and assayed for
TNF-α and sICAM-1 concentrations with commercially
available sandwich ELISA (Bender MedSystems
Diagnostics GmbH, Vienna, Austria) according to the
manufacturer’s directions.
Statistical calculations were based on parametric
tests. Group comparisons were performed using
Student’s t-test. Correlation of radiological and clinical
grading with the serum TNF-α and sICAM-1 concen-
trations was made with Pearson’s test. A probability
level of 5% was considered statistically significant.
Statistica 6.1 software (StatSoft, Inc.) was implemented
for data analysis.
RESULTS
The patients’ clinical presentation and radiological
assessment by computed tomography are shown in
Table 2. On admission, 67% of the subjects showed
signs of cerebral bleeding of different degrees (grades
2–4 on the Fisher scale). The patients’ grading accord-
ing to the GCS was between 11 and 15. Seventy-four
percent of the patients presented with grades 0–1 on the
Hunt and Hess scale. The patients’ rating on the GOS
was between 3 and 5 for 81% of the subjects. The death
rate was about 19% (5 patients died during the hospi-
talization). 
Comparisons of the parameters tested in the
patients with intracranial aneurysms vs. controls are
shown in Table 3. No differences in the mean serum
TNF-α and sICAM-1 concentrations of the aneurismal
subjects and controls were observed.
The serum TNF-α concentration did not correlate
with the radiological and clinical scores (Table 4). The
concentration of sICAM-1 positively correlated with the
Fisher grade (r=0.439) and negatively with the GOS
(r= –0.423).
Serum sICAM-1 concentration in relation to the
Fisher and the GOS grading is shown in Fig. 1. A grad-
ually increasing sICAM-1 concentration in relation to
the Fisher score was observed. The patients who scored
4 had significantly elevated serum sICAM-1 levels com-
pared with the controls. The sICAM-1 concentration
Table 1. Patients’ data
Sex (male/female) 14/13
Age (years) – mean (range) 56 (33–77)
Deaths/survivals after aneurysm rupture 5/22
Body mass index – mean (range) 28 (21–42)
Cigarette smokers/nonsmokers/data not  8/9/10
available
Alcohol drinkers (spirits ≥3 times/week)/ 0/17/9
occasional drinkers (spirits <3 times/week) 
or abstainers/data not available
Coffee drinkers (coffee consumption  9/8/10
≥3 times/week)/occasional coffee drinkers 
(<3 times/week) or nondrinkers/data 
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negatively correlated with the scores obtained from the
GOS. The patients who were graded 4 and 5 had low
serum sICAM-1 levels, comparable to those of the con-
trols. The patients who scored 1 or 3 had significantly
higher sICAM-1 levels than the controls and the
patients who scored 5.
DISCUSSION
SAH is a life-threatening consequence of an
intracranial aneurysm’s rupture, which may be lethal for
nearly 50% of patients (Inagawa et al. 1995). Disruption
of a cerebral artery causes blood extravasations which
may induce cytokine-stimulated immune reactions con-
tributing to the development of cerebral vasospasm and
ischemia. Systemic inflammation develops in a few days
after hemorrhage. TNF-α is a major cytokine in the
initiation of inflammatory reactions. Significantly
increased TNF-α levels in the cerebrospinal fluid were
observed 4–10 days after SAH (Mathiesen et al. 1997).
In the present study, early TNF-α levels were studied.
Blood samples were taken from the patients within 72
h after admittance to the hospital. The data analysis
showed similar TNF-α levels in the aneurysmal patients
and controls. No correlation of TNF-α levels with the
radiological and clinical scores was observed. In many
pathological conditions, TNF-α stimulates an inflamma-
tory response. The low TNF-α levels observed in the
sera of the aneurismal patients within three days of hos-
pitalization suggest the absence of systemic inflamma-
tion during the early hemorrhagic events. 
Leukocyte penetration through the blood-brain bar-
rier into the subarachnoidal space is facilitated by adhe-
sion molecules on the surface of endothelial cells.
sICAM-1, a released form of the membrane molecule, is
present in cerebrospinal fluid and blood. Several studies
demonstrated an increase in serum sICAM-1 after
aneurismal rupture (Frijns et al. 2006; Mack et al. 2002;
Nissen et al. 2001). Interesting observations concerning
patients’ outcome after SAH were made by Mack et al.
(Mack et al. 2002). They observed that sICAM-1 levels
were elevated in early hemorrhagic events and that late
high sICAM-1 levels were predictors of critical out-
come. Several other studies did not find significant asso-
ciations between patient outcome and serum sICAM-1
levels measured at the onset of SAH (Frijns et al. 2006;
Nissen et al. 2001). Contrary to these findings, the
Table 2. Patients’ radiological and clinical grading
Grade Fisher scale GCS Hunt and  GOS
n (%) n (%) Hess scale  n (%)
n (%)
0 – – 6 (22.2) –
1 6 (22.2) 0 14 (51.9) 5 (18.5)
2 8 (29.6) 0 0 0
3 5 (18.5) 0 2 (7.4) 2 (7.4)
4 5 (18.5) 0 2 (7.4) 7 (25.9)
5 – 0 0 13 (48.1)
6– 0 – –
7– 0 – –
8– 0 – –
9– 0 – –
10 – 0 – –
11 – 1 (3.7) – –
12 – 0 – –
13 – 4 (14.8) – –
14 – 1 (3.7) – –
15 – 18 (66.7) – –
n – number of patients.
Table 3. Serum TNF-α and sICAM-1 concentrations
(mean±SD) in patients with intracranial aneurysms 
vs. controls
Intracranial Controls p-value
aneurysms (n=17)
(n=27)
TNF-α (pg/ml) 12.42±9.70 11.29±8.80 NS
sICAM-1 (ng/ml) 255±90 225±50 NS
NS – not significant.
Table 4. Serum TNF-α and sICAM-1 concentrations in rela-
tion to radiological and clinical scores
Grade Fisher scale GCS Hunt and  GOS
n=24 n=24 Hess scale  n=27
n=24
TNF-α r =–0.055 r =0.143 r =–0.042 r =0.077
p=0.799 p=0.504 p=0.846 p=0.722
sICAM-1  r =0.439 r =–0.191 r =0.376 r=–0.423
p=0.032 p=0.372 p=0.071 p=0.039
n – number of patients.
Bold letters represent statistical significance.
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Fig. 1. Serum sICAM-1 concentration (means+SD) according to
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results obtained in the present study show associations
of early serum sICAM-1 levels with patient outcome
after SAH. The serum sICAM-1 concentration correlat-
ed with the scores obtained in the Fisher and the GOS.
The former results demonstrate a clear connection
between serum sICAM-1 concentration and the intensi-
ty of bleeding. At the same time, high sICAM-1 had
a predictive value of poor outcome. The patients who
were graded low in the GOS (1 or 3 points) had signifi-
cantly elevated sICAM-1 titers compared with the
healthy controls and the patients with the best scores. 
This study demonstrates the absence of a systemic
inflammatory TNF-α-mediated response at the onset of
subarachnoid hemorrhage. Early measurement of
serum sICAM-1 levels offers a prognostic value in the
assessment of patient outcome after brain aneurismal
rupture.
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